Streamline Health Solns STRM releases its next round of earnings this Wednesday, September 09. Get the latest predictions in Benzinga's essential guide to the company's Q2 earnings report.
Earnings and Revenue
Analysts covering Streamline Health Solns have modeled for quarterly EPS loss of $0.05 on revenue of $2.27 million. In the same quarter last year, Streamline Health Solns reported a loss per share of $0.02 on revenue of $4.79 million. The Wall Street consensus estimate for earnings per share would represent a 150.0% decrease for the company. Here's how the company's EPS has stacked up against analyst estimates in the past:
| Quarter | Q1 2020 | Q4 2020 | Q3 2020 | Q2 2019 |
|---|---|---|---|---|
| EPS Estimate | -0.06 | -0.05 | 0.03 | 0.01 |
| EPS Actual | -0.03 | -0.03 | 0.01 | -0.02 |
| Revenue Estimate | 2.58 M | 2.94 M | 5.66 M | 4.70 M |
| Revenue Actual | 2.84 M | 4.80 M | 5.79 M | 4.79 M |
Stock Performance
Over the past 52-week period, shares of Streamline Health Solns have declined 10.38%.
Considering these returns, long-term shareholders will likely be feeling unsatisfied going into this earnings release.
Don't be surprised to see the stock move on comments made during its conference call. Streamline Health Solns is scheduled to hold the call at 09:00:00 ET and can be accessed here: https://78449.themediaframe.com/dataconf/productusers/strm/mediaframe/40237/indexl.html
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
